Merck (MRK) PT Raised to $172 at HSBC
Tweet
Share
E-mailGet Alerts MRK Hot Sheet
Price: $148.78 +0.54%
Rating Summary:
24 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
24 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
HSBC analyst Rajesh Kumar raised the price target on Merck (NYSE: MRK) to $172.00 (from $150.00) while maintaining a Buy rating.
You May Also Be Interested In
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Tata Consultancy Services Ltd. (TCS:IN) PT Lowered to INR1,875 at Citi
- Ifinatamab Deruxtecan Biologics License Application for Certain Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer Voluntarily Withdrawn
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
